19
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding application number 21402.
Regulatory Information RX
With a dosage strength 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2002-07-24
Therapeutic Equivalence (TE) Code AB1,A
18
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding application number 21402.
Regulatory Information RX
With a dosage strength 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2002-07-24
Therapeutic Equivalence (TE) Code AB1,A
17
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding application number 21402.
Regulatory Information RX
With a dosage strength 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2002-07-24
Therapeutic Equivalence (TE) Code AB1,A
16
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding application number 21402.
Regulatory Information RX
With a dosage strength 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2002-07-24
Therapeutic Equivalence (TE) Code AB1,A
15
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding application number 21402.
Regulatory Information RX
With a dosage strength 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2002-07-24
Therapeutic Equivalence (TE) Code AB1,A
14
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding application number 21402.
Regulatory Information RX
With a dosage strength 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2002-07-24
Therapeutic Equivalence (TE) Code AB1,A
13
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding application number 21402.
Regulatory Information RX
With a dosage strength 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2002-07-24
Therapeutic Equivalence (TE) Code AB1,A
12
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding application number 21402.
Regulatory Information RX
With a dosage strength 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2002-07-24
Therapeutic Equivalence (TE) Code AB1,A
11
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding application number 21402.
Regulatory Information RX
With a dosage strength 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2002-07-24
Therapeutic Equivalence (TE) Code AB1,A
10
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding application number 21402.
Regulatory Information RX
With a dosage strength 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2002-07-24
Therapeutic Equivalence (TE) Code AB1,A